Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies

Name: Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
License: Public Domain

University Hospital, Caen

ClinicalTrials.gov · Datasets · License: Public Domain

chronic b-cell malignancies, btk inhibitors, cardiovascular diseases

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 181659
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.